Edwards Lifesciences (EW) Long-Term Investments (2016 - 2025)
Edwards Lifesciences has reported Long-Term Investments over the past 17 years, most recently at $278.6 million for Q4 2025.
- Quarterly results put Long-Term Investments at $278.6 million for Q4 2025, down 9.52% from a year ago — trailing twelve months through Dec 2025 was $278.6 million (down 9.52% YoY), and the annual figure for FY2025 was $278.6 million, down 9.52%.
- Long-Term Investments for Q4 2025 was $278.6 million at Edwards Lifesciences, up from $274.7 million in the prior quarter.
- Over the last five years, Long-Term Investments for EW hit a ceiling of $1.8 billion in Q4 2021 and a floor of $274.7 million in Q3 2025.
- Median Long-Term Investments over the past 5 years was $753.4 million (2021), compared with a mean of $822.2 million.
- Biggest five-year swings in Long-Term Investments: skyrocketed 128.82% in 2021 and later plummeted 58.74% in 2024.
- Edwards Lifesciences' Long-Term Investments stood at $1.8 billion in 2021, then crashed by 32.45% to $1.2 billion in 2022, then crashed by 52.87% to $583.9 million in 2023, then tumbled by 47.27% to $307.9 million in 2024, then decreased by 9.52% to $278.6 million in 2025.
- The last three reported values for Long-Term Investments were $278.6 million (Q4 2025), $274.7 million (Q3 2025), and $298.5 million (Q2 2025) per Business Quant data.